The Greenshoots Podcast by Appleyard Lees, Episode 13: the intellectual property story behind vaccines & other health innovation.
What’s behind the headlines and soundbites? Patent attorneys Richard Bray, Barbara Fleck and Kate Hickinson
Tech transfer teams’ IP challenges post-COVID-19 and beyond: part three how much data is enough in biotech and pharma patents applications?
‘Tech transfer teams’ IP challenges post-COVID-19 and beyond’ is a series of interactive virtual discussions,
In the present climate it is clear that there is enormous pressure on healthcare systems across the globe. Further, an increasingly aging population leads to a number of healthcare challenges including that people are living longer generally with one or more chronic conditions.
Appleyard Lees partners and patent attorneys David Walsh and Jennifer Delaney discuss: Is patenting ‘green’
First published in AIPLA’s Biotech Buzz newsletter, Barbara Fleck explains the Enlarged Board of Appeal’s
What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA